A general genome editing strategy using CRISPR lipid nanoparticle spherical nucleic acids
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2426094122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Zhenyu Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, IL 60208. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Nanoparticles, Lipids. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: DOD | AF | AMC | AFRL | Air Force Office of Scientific Research (AFOSR), National Science Foundation (NSF).
Abstract (Originalsprache)
Genome editing with CRISPR–Cas systems hold promise for treating a wide range of genetic disorders and cancers. However, efficient delivery of genome editors remains challenging due to the requirement for the simultaneous delivery or intracellular generation of Cas proteins, guide RNAs, and, in some applications, donor DNAs. Furthermore, the immunogenicity and toxicity of delivery vehicles can limit the safety and efficacy of genetic medicines. Here, we combine two nucleic acid delivery approaches to create CRISPR lipid nanoparticle–spherical nucleic acids (LNP–SNAs) that are both efficient and biocompatible. Compared to lipid nanoparticles (LNPs) lacking a surface-bound DNA shell, CRISPR LNP–SNAs exhibit two- to three-fold higher cellular uptake, reduced cytotoxicity, and improved gene transfection efficiency. Across multiple cell lines and genomic loci, CRISPR LNP–SNAs induce insertion–deletion mutations at average frequencies two- to three-fold higher than those observed with LNPs. When codelivered with donor templates, CRISPR LNP–SNAs enable homology-directed repair at an average efficiency of 21 ± 7%, a 2.5-fold improvement over LNPs (8 ± 4%). The ease of synthesis and biocompatibility of CRISPR LNP–SNAs highlight their potential as a versatile delivery platform for CRISPR–Cas and other gene therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, IL 60208.
ORCID-Profile: Zhenyu Han, Chi Huang, Chad A Mirkin
Förderung
- DOD | AF | AMC | AFRL | Air Force Office of Scientific Research (AFOSR)
- National Science Foundation (NSF)
Zitieren
APA
Han, Z., Huang, C., Luo, T., & Mirkin, C. A. (2025). A general genome editing strategy using CRISPR lipid nanoparticle spherical nucleic acids. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2426094122
Vancouver
Han Z, Huang C, Luo T, Mirkin CA. A general genome editing strategy using CRISPR lipid nanoparticle spherical nucleic acids. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2426094122
BibTeX
@article{Han2025,
author = {Han, Zhenyu and Huang, Chi and Luo, Taokun and Mirkin, Chad A},
title = {A general genome editing strategy using CRISPR lipid nanoparticle spherical nucleic acids},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2426094122}
}
EUVIMED